AUTHOR=Ma Shining , So Michelle , Ghelani Aazam , Srivas Rohith , Sahoo Anupama , Hall Robyn , Liu Wenjun , Wu Hao , Yu Sherman , Lu Shiping , Song Elly , Cariaga Taryn , Soto Marcus , Zhou Hong , Li Chi-Ming , Chaudhry Ashutosh , Luo Xin , Sohn Sue J. 

TITLE=Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo

JOURNAL=Frontiers in Immunology

VOLUME=14

YEAR=2023

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1257652

DOI=10.3389/fimmu.2023.1257652

ISSN=1664-3224

ABSTRACT=<p>Interleukin-2 (IL-2), along with T-cell receptor (TCR) signaling, are required to control regulatory T cell (Treg) homeostasis and function <italic>in vivo</italic>. Due to the heightened sensitivity to IL-2, Tregs retain the ability to respond to low-dose or attenuated forms of IL-2, as currently being developed for clinical use to treat inflammatory diseases. While attenuated IL-2 increases Treg selectivity, the question remains as to whether a weakened IL-2 signal sufficiently enhances Treg suppressive function(s) toward disease modification. To understand this question, we characterized the <italic>in vivo</italic> activity and transcriptomic profiles of two different attenuated IL-2 muteins in comparison with wildtype (WT) IL-2. Our study showed that, in addition to favoring Tregs, the attenuated muteins induced disproportionately robust effects on Treg activation and conversion to effector Treg (eTreg) phenotype. Our data furthermore suggested that Tregs activated by attenuated IL-2 muteins showed reduced dependence on TCR signal, at least in part due to the enhanced ability of IL-2 muteins to amplify the TCR signal <italic>in vivo</italic>. These results point to a new paradigm wherein IL-2 influences Tregs’ sensitivity to antigenic signal, and that the combination effect may be leveraged for therapeutic use of attenuated IL-2 muteins.</p>